Tango Therapeutics, Inc. — Form D
Tango Therapeutics, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2023-08-24. The offering totals $80.0M, of which $80.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2023-08-24
- Form: D
- Accession: 0001802806-23-000009
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $80.0M
- Amount sold: $80.0M
- Investors: 17
- Date of first sale: 2023-08-11
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-490627
Issuer
- Name: Tango Therapeutics, Inc.
- CIK: 0001819133
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 201 BROOKLINE AVENUE, BOSTON, MA, 02215
- Phone: (857) 320-4900
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| Aaron Ann Davis | Director | Boston, MA |
| Reid Ann Huber | Director | Boston, MA |
| Douglas Barry | Executive Officer | Boston, MA |
| Alan Huang | Executive Officer | Boston, MA |
| John Ann Ketchum | Director | Boston, MA |
| Barbara Weber | Director | Boston, MA |
| Barbara Weber | Executive Officer | Boston, MA |
| Malte Ann Peters | Director | Boston, MA |
| Kanishka Ann Pothula | Director | Boston, MA |
| Lesley Ann Calhoun | Director | Boston, MA |
| Mace Ann Rothenberg | Director | Boston, MA |
| Alexis Borisy | Director | Boston, MA |
| Adam Crystal | Executive Officer | Boston, MA |
| Daniella Beckman | Executive Officer | Boston, MA |
Other filings by this issuer (1)
More